Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
- PMID: 27404120
- PMCID: PMC6457969
- DOI: 10.1002/14651858.CD008968.pub3
Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes
Abstract
Background: Immediate delivery of the preterm fetus with suspected compromise may decrease the risk of damage due to intrauterine hypoxia. However, it may also increase the risks of prematurity.
Objectives: To assess the effects of immediate versus deferred delivery of preterm babies with suspected fetal compromise on neonatal, maternal and long-term outcomes.
Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 April 2016) and reference lists of retrieved studies.
Selection criteria: Randomised trials comparing a policy of immediate delivery with deferred delivery or expectant management in preterm fetuses with suspected in utero compromise. Quasi-randomised trials and trials employing a cluster-randomised design were eligible for inclusion but none were identified.
Data collection and analysis: Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy.
Main results: We included one trial of 548 women (588 babies) in the review. Women with pregnancies between 24 and 36 weeks' gestation took part. The study took place in 13 European countries, between 1993 and 2001. The difference in the median randomisation to delivery interval between immediate delivery and deferred delivery was four days (median: 0.9 (inter-quartile range (IQR) 0.4 to 1.3) days for immediate delivery, median: 4.9 (IQR 2.0 to 10.8) days in the delay group).There was no clear difference in the primary outcomes of extended perinatal mortality (risk ratio (RR) 1.17, 95% confidence interval (CI) 0.67 to 2.04, one trial, 587 babies, moderate-quality evidence) or the composite outcome of death or disability at or after two years of age (RR 1.22, 95% CI 0.85 to 1.75, one trial, 573 babies, moderate-quality evidence) with immediate delivery compared to deferred delivery. The results for these outcomes are consistent with both appreciable benefit and harm. More babies in the immediate delivery group were ventilated for more than 24 hours (RR 1.54, 95% CI 1.20 to 1.97, one trial, 576 babies). There were no differences between the immediate delivery and deferred delivery groups in any other infant mortality outcome (stillbirth, neonatal mortality, postneonatal mortality > 28 days to discharge), individual neonatal morbidity or markers of neonatal morbidity (cord pH less than 7.00, Apgar less than seven at five minutes, convulsions, interventricular haemorrhage or germinal matrix haemorrhage, necrotising enterocolitis and periventricular leucomalacia or ventriculomegaly).Some important outcomes were not reported, in particular infant admission to neonatal intensive care or special care facility, and respiratory distress syndrome. We were not able to calculate composite rates of serious neonatal morbidity, even though individual morbidities were reported, due to the risk of double counting infants with more than one morbidity.More children in the immediate delivery group had cerebral palsy at or after two years of age (RR 5.88, 95% CI 1.33 to 26.02, one trial, 507 children). There were, however, no differences in neurodevelopment impairment at or after two years (RR 1.72, 95% CI 0.86 to 3.41, one trial, 507 children), death at or after two years of age (RR 1.04, 95% CI 0.66 to 1.63, one trial, 573 children), or death or disability in childhood (six to 13 years of age) (RR 0.82, 95% CI 0.48 to 1.40, one trial, 302 children). More women in the immediate delivery group had caesarean delivery than in the deferred delivery group (RR 1.15, 95% CI 1.07 to 1.24, one trial, 547 women, high-quality evidence). Data were not available on any other maternal outcomes.There were several methodological weaknesses in the included study, and the level of evidence for the primary outcomes was graded high for caesarean section and moderate for extended perinatal mortality and death or disability at or after two years. The evidence was downgraded because the CIs for these outcomes were wide, and were consistent with both appreciable benefit and harm. Bias may have been introduced by several factors: blinding was not possible due to the nature of the intervention, data for childhood follow-up were incomplete due to attrition, and no adjustment was made in the analysis for the non-independence of babies from multiple pregnancies (39 out of 548 pregnancies). This study only included cases of suspected fetal compromise where there was uncertainty whether immediate delivery was indicated, thus results must be interpreted with caution.
Authors' conclusions: Currently there is insufficient evidence on the benefits and harms of immediate delivery compared with deferred delivery in cases of suspected fetal compromise at preterm gestations to make firm recommendations. There is a lack of trials addressing this question, and limitations of the one included trial means that caution must be used in interpreting and generalising the findings. More research is needed to guide clinical practice.Although the included trial is relatively large, it has insufficient power to detect differences in neonatal mortality. It did not report any maternal outcomes other than mode of delivery, or evaluate maternal satisfaction or economic outcomes. The applicability of the findings is limited by several factors: Women with a wide range of obstetric complications and gestational ages were included, and subgroup analysis is currently limited. Advances in Doppler assessment techniques may diagnose severe compromise more accurately and help make decisions about the timing of delivery. The potential benefits of deferring delivery for longer or shorter periods cannot be presumed.Where there is uncertainty whether or not to deliver a preterm fetus with suspected fetal compromise, there seems to be no benefit to immediate delivery. Deferring delivery until test results worsen or increasing gestation favours delivery may improve the outcomes for mother and baby.There is a need for high-quality randomised controlled trials comparing immediate and deferred delivery where there is suspected fetal compromise at preterm gestations to guide clinical practice. Future trials should report all important outcomes, and should be adequately powered to detect differences in maternal and neonatal morbidity and mortality.
Conflict of interest statement
Sarah Stock has received grants (paid to her institution) from NIHR HTA, SPARKS, the British Maternal and Fetal Medicine Society, and Tommy's in order to research into preterm labour and stillbirth. She has received payment (to her institution) in respect of travel expenses, accommodation and meeting costs as invited speaker about research at conferences and meetings.
Leanne Bricker ‐ none known.
Jane Norman has received a grant of £11,000 (paid to her institution) from the Chief Scientist’s Office, Scottish Executive, for an epidemiological study entitled: "Ferguson EF, Norman JE, Chalmers J, Shanks E, Finlayson A. Investigation of the beneficial and adverse effects of induction of labour." Jane Norman's has received a number of research grants (paid to her institution) to support research into improving perinatal outcome ‐ none specifically related to immediate vs deferred delivery. Jane has also received small amounts of money for speaking at meetings about prematurity but not immediate vs deferred delivery.
Helen West is paid to work on Cochrane reviews by a grant to Cochrane Pregnancy and Childbirth. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.
Figures
![1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-AFig-FIG01.gif)
![2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-AFig-FIG02.gif)
![1.1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-01.gif)
![1.2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-02.gif)
![1.3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-03.gif)
![1.4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-04.gif)
![1.5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-05.gif)
![1.6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-06.gif)
![1.7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-07.gif)
![1.8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-08.gif)
![1.9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-09.gif)
![1.10](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-10.gif)
![1.11](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-11.gif)
![1.12](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-12.gif)
![1.13](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-13.gif)
![1.14](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-14.gif)
![1.15](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-15.gif)
![1.16](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-16.gif)
![1.17](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-17.gif)
![1.18](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-18.gif)
![1.19](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6457969/bin/nCD008968-CMP-001-19.gif)
Update of
-
Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.Cochrane Database Syst Rev. 2012 Jul 11;(7):CD008968. doi: 10.1002/14651858.CD008968.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 Jul 12;7:CD008968. doi: 10.1002/14651858.CD008968.pub3. PMID: 22786520 Updated. Review.
Similar articles
-
Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome.Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004735. doi: 10.1002/14651858.CD004735.pub4. Cochrane Database Syst Rev. 2017. PMID: 28257562 Free PMC article. Review.
-
Intermittent auscultation (IA) of fetal heart rate in labour for fetal well-being.Cochrane Database Syst Rev. 2017 Feb 13;2(2):CD008680. doi: 10.1002/14651858.CD008680.pub2. Cochrane Database Syst Rev. 2017. PMID: 28191626 Free PMC article. Review.
-
Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more).Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD005302. doi: 10.1002/14651858.CD005302.pub3. Cochrane Database Syst Rev. 2017. PMID: 28050900 Free PMC article. Review.
-
Planned early delivery versus expectant management of the term suspected compromised baby for improving outcomes.Cochrane Database Syst Rev. 2015 Nov 24;2015(11):CD009433. doi: 10.1002/14651858.CD009433.pub2. Cochrane Database Syst Rev. 2015. PMID: 26599471 Free PMC article. Review.
-
Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.Cochrane Database Syst Rev. 2012 Jul 11;(7):CD008968. doi: 10.1002/14651858.CD008968.pub2. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 Jul 12;7:CD008968. doi: 10.1002/14651858.CD008968.pub3. PMID: 22786520 Updated. Review.
Cited by
-
The center-effect on outcomes for infants born at less than 25 weeks.Semin Perinatol. 2022 Feb;46(1):151538. doi: 10.1016/j.semperi.2021.151538. Epub 2021 Nov 10. Semin Perinatol. 2022. PMID: 34911651 Free PMC article. Review.
-
A systematic scoping review of clinical indications for induction of labour.PLoS One. 2020 Jan 29;15(1):e0228196. doi: 10.1371/journal.pone.0228196. eCollection 2020. PLoS One. 2020. PMID: 31995603 Free PMC article.
-
Neuroprotection from acute brain injury in preterm infants.Paediatr Child Health. 2019 Jul;24(4):276-290. doi: 10.1093/pch/pxz056. Epub 2019 Jun 21. Paediatr Child Health. 2019. PMID: 31239818 Free PMC article. Review.
-
Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment.Turk Pediatri Ars. 2018 Dec 25;53(Suppl 1):S45-S54. doi: 10.5152/TurkPediatriArs.2018.01806. eCollection 2018. Turk Pediatri Ars. 2018. PMID: 31236018 Free PMC article.
-
Delayed delivery of the second twin: Case report and literature review of diamniotic dichorionic twin pregnancy with very early preterm premature rupture of membranes.Case Rep Womens Health. 2019 Mar 19;22:e00104. doi: 10.1016/j.crwh.2019.e00104. eCollection 2019 Apr. Case Rep Womens Health. 2019. PMID: 30976524 Free PMC article.
References
References to studies included in this review
Thornton 2004 {published data only}
-
- GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and bayesian interpretation. BJOG: an international journal of obstetrics and gynaecology 2003;110:27‐32. - PubMed
-
- Hornbuckle J, Thornton JG, Vail A, GRIT Study Group. The Growth Restriction Intervention Trial (GRIT): interim progress report. Women's Health ‐ into the new millennium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3‐6; Cape Town South Africa. RCOG, 1999:76.
-
- Schneider KTM, Brocker J, Thornton J. A randomised intervention of timed delivery for the compromised preterm fetus [Randomisierte Intervention zur Optimierung des Entbindungszeitpunktes bei kompromittierten IUGR‐Feten (Euro‐GRIT)]. Geburtshilfe und Frauenheilkunde 2000;60 Suppl 1:S72.
-
- Thornton JG, Hornbuckle J, Vail A, Spiegelhalter DJ, Levene M, GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004;364:513‐20. - PubMed
-
- Walker DM, Marlow N, Upstone L, Gross H, Hornbuckle J, Vail A, et al. The growth restriction intervention trial: Long‐term outcomes in a randomized trial of timing of delivery in fetal growth restriction. American Journal of Obstetrics and Gynecology 2011;204(1):34.e1‐34.e9. - PubMed
References to studies excluded from this review
Langenveld 2011 {published data only}
-
- Langenveld J, Broekhuijsen K, Baaren GJ, Pampus MG, Kaam AH, Groen H, et al. HYPITAT‐II study group. Induction of labour versus expectant monitoring for gestational hypertension or mild pre‐eclampsia between 34 and 37 weeks' gestation (HYPITAT‐II): a multicentre, open‐label randomised controlled trial. BMC Pregnancy Childbirth 2011;11:50‐7. [PUBMED: 21736705] - PMC - PubMed
Additional references
Alberry 2007
Alfirevic 2013
Bond 2015
Bricker 2009
-
- Bricker L, Mahsud‐Dornan S, Dornan JC. Detection of foetal growth restriction using third trimester ultrasound. Best Practice & Research. Clinical Obstetrics & Gynaecology 2009;23(6):833‐44. [PUBMED: 19811955] - PubMed
Brocklehurst 2004
-
- Gates S, Brocklehurst P. How should randomised trials including multiple pregnancies be analysed?. BJOG: an international journal of obstetrics and gynaecology 2004;111(3):213‐9. - PubMed
GRIT 2003
-
- GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and bayesian interpretation. BJOG: an international journal of obstetrics and gynaecology 2003;110:27‐32. - PubMed
Grivell 2012
Grivell 2015
Guzman 1996
-
- Guzman ER, Vintzileos AM, Martins M, Benito C, Houlihan C, Hanley M. The efficacy of individual computer heart rate indices in detecting acidemia at birth in growth‐restricted fetuses. Obstetrics & Gynecology 1996;87(6):969‐74. - PubMed
Higgins 2011
-
- Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hofmeyr 2012
Hornbuckle 1999
-
- Hornbuckle J, Thornton JG, Vail A, GRIT Study Group. The Growth Restriction Intervention Trial (GRIT): interim progress report. Women's Health ‐ into the new millennium. Proceedings of the 4th International Scientific Meeting of the Royal College of Obstetricians and Gynaecologists; 1999 October 3‐6; Cape Town South Africa. RCOG, 1999:76.
Iacovidou 2010
-
- Iacovidou N, Varsami M, Syggellou A. Neonatal outcome of preterm delivery. Annals of the New York Academy of Sciences 2010;1205:130–4. - PubMed
Lalor 2008
Lees 2015
-
- Lees CC, Marlow N, Wassenaer‐Leemhuis A, Arabin B, Bilardo CM, Brezinka C, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet 2015;385(9983):2162‐72. [DOI: 10.1016/S0140-6736(14)62049-3] - DOI - PubMed
Miller 2008
-
- Miller J, Turan S, Baschat AA. Fetal growth restriction. Seminars in Perinatology 2008;32(4):274‐80. [PUBMED: 18652928] - PubMed
Nabhan 2008
RevMan 2014 [Computer program]
-
- The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Roberts 2014
Say 1996a
Say 1996b
Say 1996c
Say 1996d
Say 2001
Say 2003a
Say 2003b
Say 2003c
Schneider 2000
-
- Schneider KTM, Brocker J, Thornton J. A randomised intervention of timed delivery for the compromised preterm fetus [Randomisierte Intervention zur Optimierung des Entbindungszeitpunktes bei kompromittierten IUGR‐Feten (Euro‐GRIT)]. Geburtshilfe und Frauenheilkunde 2000;60 Suppl 1:S72.
Walker 2011
-
- Walker DM, Marlow N, Upstone L, Gross H, Hornbuckle J, Vail A, et al. The growth restriction intervention trial: Long‐term outcomes in a randomized trial of timing of delivery in fetal growth restriction. American Journal of Obstetrics and Gynecology 2011;204(1):34.e1‐34.e9. - PubMed
References to other published versions of this review
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous